
IndraLab
Statements
Resveratrol inhibits KCNH2. 4 / 4
1
|
3
reach
"In this study, we demonstrated that 1) cav-1 participates in BBR induced hERG deficiency on cell surface; 2) residues Tyr652 and Phe656, essential components of hERG binding sites, mediate hERG surface expression inhibition by BBR incubation; and 3) fexofenadine and resveratrol can shorten APD of ventricular cardiomyocytes prolonged by BBR."